Drawing for DECHRA

USPTO serial 79037451

DECHRA

Reviewed by CopyMark Law Group

Reg. 3543740Status 706Registered
Filing date
Status date
Registration date
Dec 9, 2008
Examiner
FATHY, DOMINIC
Law office
GENERIC WEB UPDATE

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with DECHRA?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nathan T. Harris

Nathan T. Harris Lando & Anastasi, LLP60 State Street, 23rd FloorBoston, MA 02109United States

Goods and services

ClassDescriptionStatusFirst use
005A house mark for a [ full ] line of veterinary preparations and substances; medicated ointments, lotions and creams for animal skin care, medicated creams [ and lotions ] for animal wound healing, treatment of skin irritations, treatment of ectoparasites and treatment of surface pyoderma, antibacterial ointments, creams and lotions for animal wound healing, treatment of skin irritations, treatment of ectoparasites and treatment of surface pyoderma, washes for animals, namely, medicated preparations for animal skincare, petroleum jelly and greases for medical and veterinary purposes, ear cleaners and dropsACTIVE—
009[ Downloadable electronic publications, in the nature of product data sheets, frequently asked question sheets and information sheets, in the field of veterinary products, veterinary screening services, veterinary diagnostic services, veterinary testing services and veterinary immunotherapy services; * all the aforesaid relating to pharmaceutical, veterinary and surgical matters and products (including apparatus and instruments) * ]SECTION 71 - CANCELLED—
010[ Syringes and needles for veterinary use ]SECTION 71 - CANCELLED—
042[ Veterinary pharmaceutical product research, evaluation and development; ] technical advice and support services, namely, those relating to veterinary pharmaceutical products [ and product licensing; veterinary laboratory services; information and advisory services relating to the aforesaid product research, evaluation and development services ]ACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 23, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 23, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 23, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 23, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 23, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 14, 2024ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Jul 29, 2023NREPNEW REPRESENTATIVE AT IB RECEIVED—
Nov 1, 2019INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Sep 6, 2019INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 6, 2019INPCINVALIDATION PROCESSED—
Aug 19, 2019INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 19, 2018NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Dec 19, 201871AGREGISTERED-SEC.71 ACCEPTED—
Dec 3, 2018ES71TEAS SECTION 71 RECEIVED—
Dec 9, 2017REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Apr 13, 2017RNWLINTERNATIONAL REGISTRATION RENEWED—
Sep 10, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 21, 2015INNPPARTIAL INVALIDATION PROCESSED BY THE IB—
Jul 31, 2015INPSPARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Jul 31, 2015INPCINVALIDATION PROCESSED—
May 9, 2015INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Sep 9, 2014NA75NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED—
Sep 9, 2014C75PREGISTERED - PARTIAL SEC. 71 ACCEPTED & SEC. 15 ACK.—
Sep 9, 2014APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 4, 2014ES75TEAS SECTION 71 & 15 RECEIVED—
Jun 1, 2013ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Apr 15, 2013INNAINVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE—
Jan 5, 2013FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jul 20, 2011INPRPARTIAL INVALIDATION OF REG EXT PROTECTION CREATED—
Oct 29, 2010CORNCORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 29, 2010LIMNLIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED—
Oct 23, 2010CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Oct 23, 2010LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Oct 20, 2010COC.CORRECTION UNDER SECTION 7 - PROCESSED—
Oct 20, 2010PLGLASSIGNED TO PARALEGAL—
Oct 20, 2010LIMELIMITATION FROM THE IB EXAMINED AND ENTERED—
Sep 13, 2010LIMGLIMITATION OF GOODS RECEIVED FROM IB—
Jul 14, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Mar 24, 2009FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 24, 2009FIMPFINAL DISPOSITION PROCESSED—
Mar 9, 2009FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
Dec 9, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 14, 2008OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Oct 30, 2008OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Oct 30, 2008OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Sep 23, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 3, 2008NPUBNOTICE OF PUBLICATION—
Aug 18, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Aug 15, 2008ALIEASSIGNED TO LIE—
Aug 8, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 8, 2008CNEAEXAMINERS AMENDMENT MAILED—
Aug 7, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Aug 7, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Feb 13, 2008CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 12, 2008CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 18, 2008TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jan 18, 2008CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 18, 2008TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Aug 10, 2007RFNTREFUSAL PROCESSED BY IB—
Jul 19, 2007RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Jul 19, 2007RFRRREFUSAL PROCESSED BY MPU—
Jul 19, 2007RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Jul 18, 2007CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 4, 2007DOCKASSIGNED TO EXAMINER—
Jun 4, 2007NWAPNEW APPLICATION ENTERED—
May 31, 2007REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance